{"id":"https://openalex.org/W2020709727","doi":"https://doi.org/10.1158/1538-7445.am10-667","title":"Abstract 667: Mechanisms underlying synergistic interactions between the CDK inhibitor flavopiridol (Alvocidib) and the BH3 mimetic GX15-070 (Obatoclax) in human multiple myeloma cells","display_name":"Abstract 667: Mechanisms underlying synergistic interactions between the CDK inhibitor flavopiridol (Alvocidib) and the BH3 mimetic GX15-070 (Obatoclax) in human multiple myeloma cells","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W2020709727","doi":"https://doi.org/10.1158/1538-7445.am10-667","mag":"2020709727"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am10-667","doi":"https://doi.org/10.1158/1538-7445.am10-667","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-667","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5029125895","display_name":"Yun Dai","orcid":"https://orcid.org/0000-0003-2285-0818","observed_orcids":["https://orcid.org/0000-0003-2285-0818"]},"institutions":[{"id":"https://openalex.org/I4390039382","display_name":"VCU Massey Comprehensive Cancer Center","ror":"https://ror.org/0173y3036","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yun Dai","raw_affiliation_strings":["1VCU Massey Cancer Ctr., Richmond, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1VCU Massey Cancer Ctr., Richmond, VA","institution_ids":["https://openalex.org/I4390039382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100443487","display_name":"Shuang Chen","orcid":"https://orcid.org/0000-0001-5254-6353","observed_orcids":["https://orcid.org/0000-0001-5254-6353","https://orcid.org/0009-0008-1028-4090"]},"institutions":[{"id":"https://openalex.org/I4390039382","display_name":"VCU Massey Comprehensive Cancer Center","ror":"https://ror.org/0173y3036","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Shuang Chen","raw_affiliation_strings":["1VCU Massey Cancer Ctr., Richmond, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1VCU Massey Cancer Ctr., Richmond, VA","institution_ids":["https://openalex.org/I4390039382"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Li Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039382","display_name":"VCU Massey Comprehensive Cancer Center","ror":"https://ror.org/0173y3036","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Li Wang","raw_affiliation_strings":["1VCU Massey Cancer Ctr., Richmond, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1VCU Massey Cancer Ctr., Richmond, VA","institution_ids":["https://openalex.org/I4390039382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041729325","display_name":"Jennifer Lynn Myers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039382","display_name":"VCU Massey Comprehensive Cancer Center","ror":"https://ror.org/0173y3036","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer Myers","raw_affiliation_strings":["1VCU Massey Cancer Ctr., Richmond, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1VCU Massey Cancer Ctr., Richmond, VA","institution_ids":["https://openalex.org/I4390039382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008581253","display_name":"Nadine Thompson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4390039382","display_name":"VCU Massey Comprehensive Cancer Center","ror":"https://ror.org/0173y3036","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Nadine Thompson","raw_affiliation_strings":["1VCU Massey Cancer Ctr., Richmond, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1VCU Massey Cancer Ctr., Richmond, VA","institution_ids":["https://openalex.org/I4390039382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069699650","display_name":"Xin\u2010Yan Pei","orcid":"https://orcid.org/0000-0003-2407-9086","observed_orcids":["https://orcid.org/0000-0003-2407-9086"]},"institutions":[{"id":"https://openalex.org/I4390039382","display_name":"VCU Massey Comprehensive Cancer Center","ror":"https://ror.org/0173y3036","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xin-Yan Pei","raw_affiliation_strings":["1VCU Massey Cancer Ctr., Richmond, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1VCU Massey Cancer Ctr., Richmond, VA","institution_ids":["https://openalex.org/I4390039382"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038235561","display_name":"Robert Zygmunt Orlowski","orcid":"https://orcid.org/0000-0002-5723-4129","observed_orcids":["https://orcid.org/0000-0002-5723-4129"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert Orlowski","raw_affiliation_strings":["2MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069980003","display_name":"Paul Dent","orcid":"https://orcid.org/0000-0001-6948-1875","observed_orcids":["https://orcid.org/0000-0001-6948-1875"]},"institutions":[{"id":"https://openalex.org/I4390039382","display_name":"VCU Massey Comprehensive Cancer Center","ror":"https://ror.org/0173y3036","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul Dent","raw_affiliation_strings":["1VCU Massey Cancer Ctr., Richmond, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1VCU Massey Cancer Ctr., Richmond, VA","institution_ids":["https://openalex.org/I4390039382"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5061036144","display_name":"Steven Grant","orcid":"https://orcid.org/0000-0003-4452-9320","observed_orcids":["https://orcid.org/0000-0003-4452-9320"]},"institutions":[{"id":"https://openalex.org/I4390039382","display_name":"VCU Massey Comprehensive Cancer Center","ror":"https://ror.org/0173y3036","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I184840846","https://openalex.org/I4390039382"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steven Grant","raw_affiliation_strings":["1VCU Massey Cancer Ctr., Richmond, VA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1VCU Massey Cancer Ctr., Richmond, VA","institution_ids":["https://openalex.org/I4390039382"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"70","issue":"8_Supplement","first_page":"667","last_page":"667"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10294","display_name":"Cell death mechanisms and regulation","score":0.002300000051036477,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/flavopiridol","display_name":"flavopiridol","score":0.9559999704360962},{"id":"https://openalex.org/keywords/obatoclax","display_name":"obatoclax","score":0.8799999952316284},{"id":"https://openalex.org/keywords/gx15-070","display_name":"GX15-070","score":0.9779999852180481},{"id":"https://openalex.org/keywords/cyclin-dependent-kinase-inhibitors","display_name":"cyclin-dependent kinase inhibitors","score":0.7789999842643738},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.8199999928474426},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9599999785423279},{"id":"https://openalex.org/keywords/drug-synergy","display_name":"drug synergy","score":0.7239999771118164},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8220000267028809},{"id":"https://openalex.org/keywords/mcl-1","display_name":"Mcl-1","score":0.8349999785423279},{"id":"https://openalex.org/keywords/bcl-xl","display_name":"Bcl-xL","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bh3-only-proteins","display_name":"BH3-only proteins","score":0.8870000243186951},{"id":"https://openalex.org/keywords/building-information-modeling","display_name":"building information modeling","score":0.8339999914169312},{"id":"https://openalex.org/keywords/pmaip1","display_name":"Noxa","score":0.8209999799728394},{"id":"https://openalex.org/keywords/puma","display_name":"PUMA","score":0.9649999737739563},{"id":"https://openalex.org/keywords/bimel","display_name":"BimEL","score":0.5189999938011169},{"id":"https://openalex.org/keywords/biml","display_name":"BimL","score":0.7170000076293945},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6729999780654907},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6200000047683716}],"concepts":[{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.6128347516059875},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5555133819580078},{"id":"https://openalex.org/C97037327","wikidata":"https://www.wikidata.org/wiki/Q5334291","display_name":"Ectopic expression","level":3,"score":0.5458978414535522},{"id":"https://openalex.org/C16930146","wikidata":"https://www.wikidata.org/wiki/Q4381253","display_name":"Stromal cell","level":2,"score":0.5422495603561401},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5331690907478333},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.4956432580947876},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.49424460530281067},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.42127302289009094},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.4210958480834961},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.3927445709705353},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2801445722579956},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2609082758426666},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18298032879829407},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.12511122226715088},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am10-667","doi":"https://doi.org/10.1158/1538-7445.am10-667","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am10-667","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.979200005531311,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.6399999856948853,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2377458274","https://openalex.org/W2409439928","https://openalex.org/W2104965094","https://openalex.org/W2124503326","https://openalex.org/W2063424779","https://openalex.org/W2027348595","https://openalex.org/W3028919400","https://openalex.org/W3029266790","https://openalex.org/W2104706142","https://openalex.org/W1991948976"],"abstract_inverted_index":{"Abstract":[0],"To":[1],"establish":[2],"a":[3,7,50,196,228,358,362],"mechanistic":[4,359],"basis":[5],"for":[6,361,422],"strategy":[8,363],"combining":[9,364],"CDK":[10,365],"inhibitors":[11,366],"and":[12,17,24,48,73,80,114,122,151,204,215,225,234,259,270,292,303,329,346,376,402],"Bcl-2":[13,160,176,368],"antagonists,":[14],"in":[15,18,29,43,49,68,92,133,149,188,199,231,238,250,306,348,370,400,403],"vitro":[16,401],"vivo":[19],"interactions":[20],"between":[21],"flavopiridol":[22],"(FP)":[23],"GX15-070":[25],"(GX)":[26],"were":[27,155,248,260,319],"investigated":[28],"human":[30],"multiple":[31,106,184,256],"myeloma":[32],"(MM)":[33],"cells.":[34,84,126,144],"The":[35,101],"activity":[36],"of":[37,56,59,95,193,241,290,338,344,373,378,386,413,418],"this":[38],"regimen":[39,102],"was":[40,103],"also":[41,87,128,335],"examined":[42],"primary":[44,134],"CD138+":[45,135],"MM":[46,52,83,90,108,125,136,252,387],"cells":[47,91,97,313],"murine":[51],"xenograft":[53],"model.":[54],"Co-administration":[55],"sub-toxic":[57],"concentrations":[58],"FP":[60,127,224,291],"interacted":[61],"synergistically":[62],"with":[63,262,282,311,321,367],"GX":[64,131,145,226,293],"to":[65,223,382,392],"induce":[66],"apoptosis":[67],"U266,":[69],"RPMI8226,":[70],"H929,":[71],"OPM-2,":[72],"MM.1S,":[74],"as":[75,77,340,342],"well":[76,341],"IL-6-dependent":[78],"ANBL6":[79],"KAS":[81],"6/1":[82],"Combination":[85],"treatment":[86],"effectively":[88],"killed":[89],"the":[93,189,239,414,419],"presence":[94,190],"stromal":[96],"or":[98,175,191,276,395],"growth":[99],"factors.":[100],"active":[104],"against":[105],"drug-resistant":[107,257],"cell":[109,253],"lines,":[110,254],"including":[111,255,389],"bortezomib/Velcade-":[112],"(U266/VR":[113],"OPM-2/VR),":[115],"Revlimid-":[116],"(8226/R10R),":[117],"dexamethasone-":[118],"(MM.1R),":[119],"melphalan-":[120],"(8226/LR5),":[121],"doxorubicin-resistant":[123],"(8226/Dox40)":[124],"sharply":[129,210],"promoted":[130],"lethality":[132],"cells,":[137,258,388],"while":[138],"sparing":[139],"normal":[140],"CD138-":[141],"bone":[142],"marrow":[143],"induced":[146,211,227],"clear":[147,197,229],"declines":[148],"Mcl-1":[150],"Bcl-xL":[152],"levels":[153],"which":[154,371],"potentiated":[156],"by":[157,171,279,299,325],"FP,":[158,187],"whereas":[159],"expression":[161,181,201,240],"did":[162],"not":[163],"change.":[164],"Significantly,":[165],"FP/GX":[166,208,286,352],"overcame":[167],"cytoprotective":[168],"effects":[169],"mediated":[170],"ectopic":[172],"Mcl-1,":[173,339],"Bcl-xL,":[174],"expression.":[177],"Notably,":[178],"BH3-only":[179,243,379],"protein":[180],"profiling":[182],"revealed":[183,336],"changes:":[185],"a)":[186],"absence":[192],"GX,":[194],"triggered":[195],"increase":[198],"Bim":[200],"(both":[202],"BimEL":[203],"BimL":[205],"isoforms);":[206],"b)":[207],"co-treatment":[209],"Bik":[212,345],"(\u223c35kDa":[213],"species)":[214],"Noxa":[216,277,347],"(\u223c27":[217],"kDa":[218],"species),;":[219],"c)":[220,235],"co-exposure":[221],"(24hr)":[222],"reduction":[230],"Puma":[232],"expression;":[233],"no":[236],"changes":[237],"other":[242],"proteins":[244,375,380],"occurred.":[245],"These":[246,317],"findings":[247,356],"confirmed":[249],"various":[251],"associated":[261,320],"Bak/Bax":[263],"activation,":[264],"Bax":[265],"translocation,":[266],"cytochrome":[267],"C":[268],"release,":[269],"caspase":[271,326],"activation.":[272],"Importantly,":[273],"Bim,":[274],"Bik,":[275],"knock-down":[278],"stable":[280],"transfection":[281],"shRNA":[283],"dramatically":[284],"diminished":[285,300],"lethality.":[287],"Lastly,":[288],"co-administration":[289],"significantly":[294],"suppressed":[295],"tumor":[296,301,349],"growth,":[297],"reflected":[298],"size":[302],"bioluminescence":[304],"intensity,":[305],"athymic":[307],"nude":[308],"mice":[309],"inoculated":[310],"8226":[312],"stably":[314],"expressing":[315],"luciferase.":[316],"events":[318],"pronounced":[322],"apoptosis,":[323],"manifested":[324],"3":[327],"activation":[328],"PARP":[330],"degradation.":[331],"Western":[332],"blot":[333],"analysis":[334],"down-regulation":[337,372],"up-regulation":[343],"tissues":[350],"following":[351],"co-administration.":[353],"Collectively,":[354],"these":[355],"provide":[357],"framework":[360],"antagonists":[369],"anti-apoptotic":[374],"induction":[377],"cooperate":[381],"trigger":[383],"synergistic":[384],"killing":[385],"those":[390],"resistant":[391],"either":[393],"conventional":[394],"novel":[396],"anti-MM":[397],"agents,":[398],"both":[399],"vivo.":[404],"Citation":[405],"Format:":[406],"{Authors}.":[407],"{Abstract":[408],"title}":[409],"[abstract].":[410],"In:":[411],"Proceedings":[412],"101st":[415],"Annual":[416],"Meeting":[417],"American":[420],"Association":[421],"Cancer":[423,433],"Research;":[424],"2010":[425],"Apr":[426],"17-21;":[427],"Washington,":[428],"DC.":[429],"Philadelphia":[430],"(PA):":[431],"AACR;":[432],"Res":[434],"2010;70(8":[435],"Suppl):Abstract":[436],"nr":[437],"667.":[438]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}